We are a purpose-driven medical device company leveraging cutting-edge advances in biomaterials to provide effective, affordable advanced wound care solutions to patients across the socioeconomic spectrum and around the world. After more than a decade of research and development, ProgenaCare Global is commercializing ProgenaMatrix®, the first product built on our proprietary human keratin platform. ProgenaMatrix is the only commercially available human keratin matrix for wound care. Due to its unique keratin technology, ProgenaMatrix is capable of providing excellent outcomes for patients with complex wounds in a highly cost-effective manner.